A detailed history of Brown, Lisle/Cummings, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 120 shares of BAX stock, worth $3,915. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120
Previous 120 -0.0%
Holding current value
$3,915
Previous $4.01 Million 13.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 28, 2024

SELL
$37.88 - $43.77 $10,606 - $12,255
-280 Reduced 70.0%
120 $5.13 Million
Q1 2023

Jun 28, 2024

SELL
$37.58 - $52.57 $4,885 - $6,834
-130 Reduced 24.53%
400 $16.2 Million
Q4 2021

Jun 28, 2024

BUY
$74.57 - $87.19 $39,522 - $46,210
530 New
530 $45.5 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.4B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Brown, Lisle/Cummings, Inc. Portfolio

Follow Brown, Lisle/Cummings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown, Lisle/Cummings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brown, Lisle/Cummings, Inc. with notifications on news.